23:02 IST
BSE
Management Change
OneSource Specialty Pharma Management Change
Onesource Specialty Pharma Limited appointed B S R & Co LLP as its Statutory Auditor for a 60-month term, effective September 23, 2026.
OneSource Specialty Pharma Ltd
- Share price
- ₹1,530.00
- Market cap
- ₹17,545 Cr
- Revenue (annual)
- ₹1,422 Cr
- Net profit (annual)
- ₹-73.80 Cr
- P/E (TTM)
- -360.9×Sector 47.4×
- Promoter holding
- 30.48%+0.00% QoQ
- FII holding
- 19.19%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
All
Employee Stock Options 10Regulatory Approval 5Other Announcement 5Management Change 5Financial Results 5Earnings Call 4Annual General Meeting 3Results Update 2Board Meeting Date 2Price Movement Clarification 1New Order Win 1Credit Rating 1Capacity Expansion 1Business Update 1Annual Report 1Adverse Business Impact 1
Time
5 announcements with these filters
19:46 IST
BSE
Management Change
OneSource Specialty Pharma Management Change
OneSource Specialty Pharma announced Preeti Kalra as a new Senior Management Personnel, while Ravi Kumar has resigned from his SMP position effective July 24, 2026.
10:44 IST
BSE
Management Change
OneSource Specialty Pharma Management Change
Prateek Gupta resigned as Senior Vice President and Head – Technical Development. He was relieved from OneSource Specialty Pharma effective May 15, 2026.
14:01 IST
NSE
Management Change
OneSource Specialty Pharma Management Change
Onesource Specialty Pharma appointed B S R & Co. LLP as Statutory Auditor for five years. The firm serves several major listed companies in the pharma sector.
- Execution
- 60 months
13:09 IST
NSE
Management Change
OneSource Specialty Pharma Management Change
Prateek Gupta resigned as SVP & Head – Technical Development at OneSource Specialty Pharma effective May 13, 2026. This senior management exit follows SEBI regulatory disclosure requirements.